159 related articles for article (PubMed ID: 35158968)
21. Immunoassay for wild-type protein in lymphocytes predicts germline mutations in patients at risk for hereditary colorectal cancer.
Fields JZ; Gao Z; Gao Z; Lewis M; Maimonis P; Harvey J; Lynch HT; Boman BM
J Lab Clin Med; 2004 Jan; 143(1):59-66. PubMed ID: 14749686
[TBL] [Abstract][Full Text] [Related]
22. Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer.
Esteban-Jurado C; Vila-Casadesús M; Garre P; Lozano JJ; Pristoupilova A; Beltran S; Muñoz J; Ocaña T; Balaguer F; López-Cerón M; Cuatrecasas M; Franch-Expósito S; Piqué JM; Castells A; Carracedo A; Ruiz-Ponte C; Abulí A; Bessa X; Andreu M; Bujanda L; Caldés T; Castellví-Bel S
Genet Med; 2015 Feb; 17(2):131-42. PubMed ID: 25058500
[TBL] [Abstract][Full Text] [Related]
23. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.
Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA
Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471
[TBL] [Abstract][Full Text] [Related]
24. NTHL1 biallelic mutations seldom cause colorectal cancer, serrated polyposis or a multi-tumor phenotype, in absence of colorectal adenomas.
Belhadj S; Quintana I; Mur P; Munoz-Torres PM; Alonso MH; Navarro M; Terradas M; Piñol V; Brunet J; Moreno V; Lázaro C; Capellá G; Valle L
Sci Rep; 2019 Jun; 9(1):9020. PubMed ID: 31227763
[TBL] [Abstract][Full Text] [Related]
25. New genes emerging for colorectal cancer predisposition.
Esteban-Jurado C; Garre P; Vila M; Lozano JJ; Pristoupilova A; Beltrán S; Abulí A; Muñoz J; Balaguer F; Ocaña T; Castells A; Piqué JM; Carracedo A; Ruiz-Ponte C; Bessa X; Andreu M; Bujanda L; Caldés T; Castellví-Bel S
World J Gastroenterol; 2014 Feb; 20(8):1961-71. PubMed ID: 24587672
[TBL] [Abstract][Full Text] [Related]
26. [Hereditary predisposition of colorectal cancer and prevalence of hereditary nonpolyposis colorectal cancer in general population of colorectal cancer patients in China].
Zhang YZ; Sheng JQ; Li SR; Wu ZT
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2995-3000. PubMed ID: 16324388
[TBL] [Abstract][Full Text] [Related]
27. Contribution of bi-allelic germline MUTYH mutations to early-onset and familial colorectal cancer and to low number of adenomatous polyps: case-series and literature review.
Knopperts AP; Nielsen M; Niessen RC; Tops CM; Jorritsma B; Varkevisser J; Wijnen J; Siezen CL; Heine-Bröring RC; van Kranen HJ; Vos YJ; Westers H; Kampman E; Sijmons RH; Hes FJ
Fam Cancer; 2013 Mar; 12(1):43-50. PubMed ID: 23007840
[TBL] [Abstract][Full Text] [Related]
28. NRAS germline variant G138R and multiple rare somatic mutations on APC in colorectal cancer patients in Taiwan by next generation sequencing.
Chang PY; Chen JS; Chang NC; Chang SC; Wang MC; Tsai SH; Wen YH; Tsai WS; Chan EC; Lu JJ
Oncotarget; 2016 Jun; 7(25):37566-37580. PubMed ID: 27121310
[TBL] [Abstract][Full Text] [Related]
29. Mosaicism in Patients With Colorectal Cancer or Polyposis Syndromes: A Systematic Review.
Jansen AML; Goel A
Clin Gastroenterol Hepatol; 2020 Aug; 18(9):1949-1960. PubMed ID: 32147591
[TBL] [Abstract][Full Text] [Related]
30. Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in
Nieminen TT; Walker CJ; Olkinuora A; Genutis LK; O'Malley M; Wakely PE; LaGuardia L; Koskenvuo L; Arola J; Lepistö AH; Brock P; Yilmaz AS; Eisfeld AK; Church JM; Peltomäki P; de la Chapelle A
Thyroid; 2020 Mar; 30(3):380-388. PubMed ID: 32024448
[No Abstract] [Full Text] [Related]
31. EPHB2 germline variants in patients with colorectal cancer or hyperplastic polyposis.
Kokko A; Laiho P; Lehtonen R; Korja S; Carvajal-Carmona LG; Järvinen H; Mecklin JP; Eng C; Schleutker J; Tomlinson IP; Vahteristo P; Aaltonen LA
BMC Cancer; 2006 Jun; 6():145. PubMed ID: 16740153
[TBL] [Abstract][Full Text] [Related]
32. Pathology of the hereditary colorectal carcinoma.
Gatalica Z; Torlakovic E
Fam Cancer; 2008; 7(1):15-26. PubMed ID: 17564815
[TBL] [Abstract][Full Text] [Related]
33. Whole Gene Capture Analysis of 15 CRC Susceptibility Genes in Suspected Lynch Syndrome Patients.
Jansen AM; Geilenkirchen MA; van Wezel T; Jagmohan-Changur SC; Ruano D; van der Klift HM; van den Akker BE; Laros JF; van Galen M; Wagner A; Letteboer TG; Gómez-García EB; Tops CM; Vasen HF; Devilee P; Hes FJ; Morreau H; Wijnen JT
PLoS One; 2016; 11(6):e0157381. PubMed ID: 27300758
[TBL] [Abstract][Full Text] [Related]
34. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
[TBL] [Abstract][Full Text] [Related]
35.
Terradas M; Mur P; Belhadj S; Woodward ER; Burghel GJ; Munoz-Torres PM; Quintana I; Navarro M; Brunet J; Lazaro C; Pineda M; Moreno V; Capella G; Evans DGR; Valle L
Gut; 2021 Jun; 70(6):1139-1146. PubMed ID: 32998877
[TBL] [Abstract][Full Text] [Related]
36. Copy number variants associated with 18p11.32, DCC and the promoter 1B region of APC in colorectal polyposis patients.
Masson AL; Talseth-Palmer BA; Evans TJ; McElduff P; Spigelman AD; Hannan GN; Scott RJ
Meta Gene; 2016 Feb; 7():95-104. PubMed ID: 26909336
[TBL] [Abstract][Full Text] [Related]
37. A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis.
Hong Y; Ho KS; Eu KW; Cheah PY
Clin Cancer Res; 2007 Feb; 13(4):1107-14. PubMed ID: 17317818
[TBL] [Abstract][Full Text] [Related]
38. The Fanconi anemia DNA damage repair pathway in the spotlight for germline predisposition to colorectal cancer.
Esteban-Jurado C; Franch-Expósito S; Muñoz J; Ocaña T; Carballal S; López-Cerón M; Cuatrecasas M; Vila-Casadesús M; Lozano JJ; Serra E; Beltran S; Brea-Fernández A; Ruiz-Ponte C; Castells A; Bujanda L; Garre P; Caldés T; Cubiella J; Balaguer F; Castellví-Bel S
Eur J Hum Genet; 2016 Oct; 24(10):1501-5. PubMed ID: 27165003
[TBL] [Abstract][Full Text] [Related]
39. Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols.
Vasen HF; Taal BG; Griffioen G; Nagengast FM; Cats A; Menko FH; Oskam W; Kleibeuker JH; Offerhaus GJ; Khan PM
Gut; 1994 Sep; 35(9):1262-6. PubMed ID: 7959234
[TBL] [Abstract][Full Text] [Related]
40. Identification of Novel Candidate Genes for Early-Onset Colorectal Cancer Susceptibility.
de Voer RM; Hahn MM; Weren RD; Mensenkamp AR; Gilissen C; van Zelst-Stams WA; Spruijt L; Kets CM; Zhang J; Venselaar H; Vreede L; Schubert N; Tychon M; Derks R; Schackert HK; Geurts van Kessel A; Hoogerbrugge N; Ligtenberg MJ; Kuiper RP
PLoS Genet; 2016 Feb; 12(2):e1005880. PubMed ID: 26901136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
